Sarepta Blinks In Showdown With FDA

In this week’s edition of InnovationRx, we look at Sarepta’s showdown with the FDA, Moderna’s use of quantum computers, a new top drug regulator at the FDA, ARCH Venture’s latest biotech company, and more. To get it in your inbox, subscribe here.

Usually when the FDA asks a drugmaker to halt distribution of a treatment, the company complies.

Last week, in a remarkable showdown, Sarepta Therapeutics refused to stop…